• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人α1-肾上腺素能受体亚型的偶联效率:用可诱导和可抑制表达载体滴定受体密度和反应性。

Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors.

作者信息

Theroux T L, Esbenshade T A, Peavy R D, Minneman K P

机构信息

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

出版信息

Mol Pharmacol. 1996 Nov;50(5):1376-87.

PMID:8913370
Abstract

We compared the efficiencies with which human alpha 1-adrenergic receptor (AR) subtypes activate inositol phosphate (InsP) formation and increase intracellular Ca2+ in transfected cell lines. Expression of human alpha 1a-, alpha 1b-, and alpha 1d-AR cDNAs under the repressible control of anhydrotetracycline in human embryonic kidney (HEK) 293 cells, which normally express no alpha 1-ARs, was used to compare responses to norepinephrine (NE) at different receptor densities. Maximal NE-stimulated InsP formation was found to increase with increasing density of each subtype, whereas basal levels and responses to sodium fluoride did not change. A comparison of multiple subclones over equivalent ranges of receptor expression showed that activation of each subtype resulted in different maximal responses (alpha 1a > alpha 1b > alpha 1d) in HEK 293 cells. Analogous studies were carried out in human SK-N-MC cells, which normally express low levels of all three alpha 1-AR subtypes, using an isopropyl-beta-D-thiogalactoside-inducible expression system. Induction with isopropyl-beta-D-thiogalactoside increased the density of individual alpha 1-AR subtypes by 4-6-fold over the level of endogenous expression. Increased expression of each of these subtypes in SK-N-MC cells did not alter the EC50 value for NE in stimulating InsP formation or releasing [Ca2+]i but did increase maximal responses to NE. Similar to our findings in HEK 293 cells, a comparison of responses at similar expression levels in SK-N-MC cells showed different maximal responses stimulated by each subtype, for both InsP (alpha 1a > alpha 1b > or = alpha 1d) and [Ca2+]i (alpha 1a > alpha 1b > alpha 1d) responses. These studies show that agonist-occupied human alpha 1-AR subtypes have different efficiencies in activating phospholipase C in human cell lines. In both HEK 293 and SK-N-MC cells, alpha 1a-ARs couple most efficiently, whereas alpha 1d-ARs couple very poorly.

摘要

我们比较了人类α1 - 肾上腺素能受体(AR)亚型在转染细胞系中激活肌醇磷酸(InsP)形成和增加细胞内Ca2+的效率。在通常不表达α1 - ARs的人胚肾(HEK)293细胞中,利用脱水四环素的可抑制控制来表达人类α1a -、α1b - 和α1d - AR的cDNA,以此比较在不同受体密度下对去甲肾上腺素(NE)的反应。发现最大NE刺激的InsP形成随着每种亚型密度的增加而增加,而基础水平和对氟化钠的反应没有变化。对受体表达等效范围内的多个亚克隆进行比较表明,在HEK 293细胞中,每种亚型的激活导致不同的最大反应(α1a > α1b > α1d)。在通常表达所有三种α1 - AR亚型低水平的人SK - N - MC细胞中,使用异丙基 - β - D - 硫代半乳糖苷诱导表达系统进行了类似研究。用异丙基 - β - D - 硫代半乳糖苷诱导使单个α1 - AR亚型的密度比内源性表达水平增加4 - 6倍。这些亚型在SK - N - MC细胞中表达增加并没有改变NE刺激InsP形成或释放[Ca2+]i的EC50值,但确实增加了对NE的最大反应。与我们在HEK 293细胞中的发现相似,对SK - N - MC细胞中相似表达水平的反应进行比较表明,对于InsP(α1a > α1b > 或 = α1d)和[Ca2+]i(α1a > α1b > α1d)反应,每种亚型刺激的最大反应不同。这些研究表明,激动剂占据的人类α1 - AR亚型在人类细胞系中激活磷脂酶C的效率不同。在HEK 293和SK - N - MC细胞中,α1a - ARs的偶联最有效,而α1d - ARs的偶联非常差。

相似文献

1
Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors.人α1-肾上腺素能受体亚型的偶联效率:用可诱导和可抑制表达载体滴定受体密度和反应性。
Mol Pharmacol. 1996 Nov;50(5):1376-87.
2
Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells.人α1d - 肾上腺素能受体的克隆及三种人类亚型在SK - N - MC细胞中的诱导表达。
Mol Pharmacol. 1995 May;47(5):977-85.
3
Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.克隆的α1-肾上腺素能受体亚型激动剂的选择性
Mol Pharmacol. 1994 Nov;46(5):929-36.
4
[Different susceptibilities to desensitization of three alpha 1-adrenoceptor subtypes induced by sustained norepinephrine stimulation].
Sheng Li Xue Bao. 1997 Feb;49(1):1-6.
5
Increased voltage-dependent calcium influx produced by alpha 1B-adrenergic receptor activation in rat medullary thyroid carcinoma 6-23 cells.α1B - 肾上腺素能受体激活在大鼠甲状腺髓样癌6 - 23细胞中产生的电压依赖性钙内流增加。
Mol Pharmacol. 1994 Apr;45(4):591-8.
6
The N terminus of the human alpha1D-adrenergic receptor prevents cell surface expression.人类α1D-肾上腺素能受体的N端可阻止其在细胞表面表达。
J Pharmacol Exp Ther. 2004 Apr;309(1):388-97. doi: 10.1124/jpet.103.060509. Epub 2004 Jan 12.
7
Cell proliferation and Ca(2+)-calmodulin dependent protein kinase activation mediated by alpha 1A- and alpha 1B-adrenergic receptor in HEK293 cells.
Acta Pharmacol Sin. 2000 Jan;21(1):55-9.
8
Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells.人胚肾293细胞中共表达的α1a-和α1b-肾上腺素能受体的药理学特性及相互作用
J Pharmacol Exp Ther. 2004 Apr;309(1):259-66. doi: 10.1124/jpet.103.061796. Epub 2004 Jan 13.
9
Binding, partial agonism, and potentiation of alpha(1)-adrenergic receptor function by benzodiazepines: A potential site of allosteric modulation.苯二氮䓬类药物对α(1)-肾上腺素能受体功能的结合、部分激动作用及增强作用:变构调节的一个潜在位点。
J Pharmacol Exp Ther. 1999 Dec;291(3):1164-71.
10
Relationship between alpha(1)-adrenergic receptor-induced contraction and extracellular signal-regulated kinase activation in the bovine inferior alveolar artery.牛下牙槽动脉中α₁-肾上腺素能受体诱导的收缩与细胞外信号调节激酶激活之间的关系
J Pharmacol Exp Ther. 2002 Oct;303(1):403-11. doi: 10.1124/jpet.102.037531.

引用本文的文献

1
Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.肾上腺素能受体:受体、配体及其临床用途,分子药理学和检测。
Handb Exp Pharmacol. 2024;285:55-145. doi: 10.1007/164_2024_713.
2
The prognostic value of ADRA1 subfamily genes in gastric carcinoma.ADRA1亚家族基因在胃癌中的预后价值
Oncol Lett. 2019 Sep;18(3):3150-3158. doi: 10.3892/ol.2019.10660. Epub 2019 Jul 24.
3
Genetic variation in the alpha-adrenergic receptor and vascular response.α-肾上腺素能受体的基因变异与血管反应
Pharmacogenomics J. 2017 Jul;17(4):366-371. doi: 10.1038/tpj.2016.29. Epub 2016 Apr 19.
4
α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.α1D-肾上腺素受体负责介导导血管中去甲肾上腺素引起的收缩的高灵敏度和慢时程。
Pharmacol Res Perspect. 2013 Oct;1(1):e00001. doi: 10.1002/prp2.1. Epub 2013 Aug 28.
5
Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.α1A - 肾上腺素能受体的基因变异与去氧肾上腺素介导的静脉收缩
Pharmacogenomics J. 2015 Aug;15(4):310-5. doi: 10.1038/tpj.2014.69. Epub 2014 Nov 25.
6
Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling.用低分子量化合物靶向LINGO-1的顺式二聚化会影响其下游信号传导。
Br J Pharmacol. 2015 Feb;172(3):841-56. doi: 10.1111/bph.12945. Epub 2014 Dec 15.
7
Altered expression profile of renal α(1D)-adrenergic receptor in diabetes and its modulation by PPAR agonists.糖尿病中肾α(1D)-肾上腺素能受体表达谱的改变及其受PPAR激动剂的调节
J Diabetes Res. 2014;2014:725634. doi: 10.1155/2014/725634. Epub 2014 Mar 17.
8
Differences in the signaling pathways of α(1A)- and α(1B)-adrenoceptors are related to different endosomal targeting.α(1A)-和α(1B)-肾上腺素受体的信号通路差异与不同的内体靶向有关。
PLoS One. 2013 May 24;8(5):e64996. doi: 10.1371/journal.pone.0064996. Print 2013.
9
Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.下尿路 α(1)-肾上腺素能受体的表型药理学。
Br J Pharmacol. 2012 Mar;165(5):1226-34. doi: 10.1111/j.1476-5381.2011.01591.x.
10
Differential modulation of α-1 adrenoceptor subtypes by antidepressants in the rat brain.抗抑郁药在大鼠脑中对α-1 肾上腺素受体亚型的差异调节。
J Neural Transm (Vienna). 2010 Dec;117(12):1423-30. doi: 10.1007/s00702-010-0522-4. Epub 2010 Dec 7.